These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17216011)

  • 41. Integration of host-related signatures with cancer cell-derived predictors for the optimal management of anticancer chemotherapy.
    Zitvogel L; Kepp O; Aymeric L; Ma Y; Locher C; Delahaye NF; André F; Kroemer G
    Cancer Res; 2010 Dec; 70(23):9538-43. PubMed ID: 21098713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Researchers hope new database becomes universal cancer genomics tool.
    Martin M
    J Natl Cancer Inst; 2012 Jul; 104(14):1045-7. PubMed ID: 22781431
    [No Abstract]   [Full Text] [Related]  

  • 43. [Individuated molecular target chemotherapy].
    Yamamoto W; Endo W; Sato A; Matsukawa M
    Nihon Rinsho; 2002 Jan; 60(1):168-73. PubMed ID: 11808329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Role of contemporary pathological diagnostics in the personalized treatment of cancer].
    Tímár J
    Magy Onkol; 2013 Mar; 57(1):26-32. PubMed ID: 23573519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of Potential Diagnostic and Prognostic Values of
    Li M; Wu F; Zheng Q; Wu Y; Wu Y
    DNA Cell Biol; 2020 May; 39(5):909-917. PubMed ID: 32150689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Molecular diagnostics in oncology].
    Imianitov EN
    Vopr Onkol; 2012; 58(2):153-63. PubMed ID: 22774518
    [No Abstract]   [Full Text] [Related]  

  • 47. Genomics and the continuum of cancer care.
    McDermott U; Downing JR; Stratton MR
    N Engl J Med; 2011 Jan; 364(4):340-50. PubMed ID: 21268726
    [No Abstract]   [Full Text] [Related]  

  • 48. Metabolomics in cancer: a bench-to-bedside intersection.
    Claudino WM; Goncalves PH; di Leo A; Philip PA; Sarkar FH
    Crit Rev Oncol Hematol; 2012 Oct; 84(1):1-7. PubMed ID: 22429650
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genomic medicine for cancer prognosis.
    Mathur A; Zeiger MA
    J Surg Oncol; 2015 Jan; 111(1):31-7. PubMed ID: 25111527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Getting our priorities straight: a novel framework for stakeholder-informed prioritization of cancer genomics research.
    Esmail LC; Roth J; Rangarao S; Carlson JJ; Thariani R; Ramsey SD; Veenstra DL; Deverka P
    Genet Med; 2013 Feb; 15(2):115-22. PubMed ID: 23037935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Companion diagnostics.
    Becker R; Mansfield E
    Clin Adv Hematol Oncol; 2010 Jul; 8(7):478-9. PubMed ID: 20864915
    [No Abstract]   [Full Text] [Related]  

  • 52. Asuragen Inc.
    Labourier E; Winkler M
    Pharmacogenomics; 2008 Jun; 9(6):675-80. PubMed ID: 18518846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer genome sequencing and potential application in oncology.
    Katsios C; Zoras O; Roukos DH
    Future Oncol; 2010 Oct; 6(10):1527-31. PubMed ID: 21062151
    [No Abstract]   [Full Text] [Related]  

  • 54. Genomic medicine for cancer diagnosis.
    Gordon BL; Finnerty BM; Aronova A; Fahey TJ
    J Surg Oncol; 2015 Jan; 111(1):24-30. PubMed ID: 25346009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathology vs. prognosis: are hereditary cancers a different breed?
    Saphir A
    J Natl Cancer Inst; 1998 Jun; 90(12):880-2. PubMed ID: 9637134
    [No Abstract]   [Full Text] [Related]  

  • 56. Functional genomics lead to new therapies in follicular lymphoma.
    Oricchio E; Wendel HG
    Ann N Y Acad Sci; 2013 Jul; 1293():18-24. PubMed ID: 23676193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Financial implications of Idylla testing in colorectal cancer, lung cancer and melanoma: a French laboratory point of view.
    Le Flahec G; Guibourg B; Marcorelles P; Uguen A
    J Clin Pathol; 2017 Oct; 70(10):906-907. PubMed ID: 28798207
    [No Abstract]   [Full Text] [Related]  

  • 58. Cell kinetics and in vitro chemosensitivity as a tool for improved management of patients.
    Silvestrini R; Daidone MG; Costa A; Sanfilippo O
    Eur J Cancer Clin Oncol; 1985 Mar; 21(3):371-8. PubMed ID: 4007012
    [No Abstract]   [Full Text] [Related]  

  • 59. Market watch: emerging companion diagnostics for cancer drugs.
    August J
    Nat Rev Drug Discov; 2010 May; 9(5):351. PubMed ID: 20431558
    [No Abstract]   [Full Text] [Related]  

  • 60. Genomics of lung cancer may change diagnosis, prognosis and therapy.
    Kopper L; Tímár J
    Pathol Oncol Res; 2005; 11(1):5-10. PubMed ID: 15800676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.